The first step to create Regulatory Intelligence is to find the raw regulatory information. Below are tools to help launch your navigation to global regulatory information sites.
This table provides an overview of all RI tools offered by RAPS.
This table provides an overview of industry associations, trade associations (company membership) and professional associations that provide information for regulatory professionals.
One of the greatest sources of RI can be found in the press and knowing where to find the journals is key.
This table provides a source of competitive and business intelligence websites.
If you need help conducting RI or creating a strategic plan, RI providers can assist, but sometimes half the challenge is finding the vendors.
Sometimes you need help and assistance in your RI needs and an RI database provider can be the answer, but first you have to evaluate them and understand what each contributes. The first step, like everything else in RI, is knowing where to find the vendor or information.
When you want to learn a new skill, or expand your current knowledge base, you need to know where to find educational training. Table 7 includes both vendors and Health Authority (HA) offerings.
This table includes vendors that provide information and updates on the outcome of FDA Advisory Committees.
This table provides some little-known manufacturing information sites that RI professionals will find helpful in searching for drug master files or other quality information.
If you have any questions about orphan drug designations, this table provides the list of who to contact.
When you have an orphan drug, you need to know all the orphan drug regulations around the globe and how they compare so you can create and submit an orphan drug designation/application.
Even though orphan drug submissions use the same name, their actual requirements differ by country. This table provides the templates for some orphan drug submissions.
Want to know if other companies have obtained orphan product designation for the same indication? This table provides the listing of the searchable databases.
If you need help with the indication or determining the population prevalence or incidence, the advocacy groups in this table can help.
Currently accepted clinical trial endpoints and competitive intelligence can be found on clinical trial registry websites. This table provides a listing of known registries.
When you are planning a generic drug submission, it is important to know all the regulations to plan the submission and how the applications differ by country.
This table provides a listing of regulatory authorities by region.
Keeping up on global changes is imperative. This table provides a list of global harmonization initiatives.
Sometimes the hardest part of creating strategy is locating precedent. This table contains links to approval information by country and region.
This table includes links to publicly disclosed compliance and inspection information from FDA.
An overview by country of the available regulations and requirements for the development of biosimilar products is provided in this table.
Table 1. RAPS Regulatory Focus Surveillance Tools
Table 2. Industry, Trade and Professional Regulatory Associations
AdvaMed
American Association of Pharmaceutical Scientists
Association of Clinical Research Professionals
Association of Clinical Research Organizations
Biotechnology Industry Organization
BIOTECanada
Canadian Association of Professional Regulatory Affairs
Canadian Cosmetic, Toiletry and Fragrance Association
The Canadian Generic Pharmaceutical Association
Cosmetics, Toiletry and Fragrance Association
Consumer Health Products Canada
Drug Information Association
Innovation Medicines Canada
European Medical Technology
European Federation of Pharmaceutical Industries and Associations
European Generic Medicines Association
European Association for Bioindustries
European Vaccine Manufacturers
Federation of Pharmaceutical Manufacturers’ Associations of Japan
Food and Drug Law Institute
Generic Pharmaceutical Association
International Federation of Pharmaceutical Manufacturers and Associations
Japanese Pharmaceutical Manufacturer Association
Japanese Self Medication Industry Association
Medical Device Manufacturers Association
National Association of Pharmacy Regulatory Authorities
North Carolina Regulatory Affairs Forum
Orange Country Regulatory Affairs Discussion Group
Parenteral Drug Association
Pharmaceutical Research and Manufacturers of America
Proprietary Association of Great Britain
Pharmaceutical Society of Singapore
Regulatory Affairs Professionals Society
Royal Pharmaceutical Society
The Organization for Professionals in Regulatory Affairs
United States Pharmacy Boards
Table 3. Regulatory Alerts, Updates, Newsletters, Journals, Subscriptions and Services
Applied Clinical Trials
Asia-Pacific Newsletter
Bioworld Today
Bio Discovery
Drug Information Association Therapeutic Innovation and Regulatory Science Journal
FDA Info
FDA Webview
Food and Drug Law Institute Journal
Inside Health Policy News Stand
In-Pharma Technologist
List Servers HHS (NIH/NLM and FDA)
Nature
Pharmaceutical Executive Magazine
Pharmaceutical Technology
PriceWaterhouseCoopers Pharma and Life Sciences
Regulatory Focus
Regulatory Rapporteur
Table 4. Business Intelligence Websites
Table 5. Regulatory Information/Research Providers and RI Sites
Table 6. Specialized Regulatory Information Databases and Alerts (Paid Subscription)
Table 7. Educational Resources
Cato Research
CBER Learn
CDER Learn
Center for Professional Advancement
CDER Small Business and Industry Education Series
CDRH Learn
Center for Professional Innovation and Education
Institute for International Research
International Quality and Productivity Center
Management Forum
Pharmaceutical Education and Research Institute
Pharmaceutical Training Institute
Pharma Conference
Zenosis
Table 8. Fee-Based Advisory Committee Updates (Other Than FDA)
Table 9. Manufacturing and Quality Health Authority Databases (US and EU)
Pharmeuropa archives
Search through a continuously updated database for information on Ph.Eur Reference Standards.
More about Ph.Eur Standards
Place an order
Search Knowledge
Latest Ph.Eur News
Certification News
Table 10. Global Health Authority Orphan Drug Office
Table 11. Orphan Drug Regulations by Country
Country | Regulation/Directive |
---|---|
US | 21 CFR 316 |
EU | Regulation (EC) No 141/2000 (the Orphan Regulation) Regulation (EC) No 847/2000 |
Japan | Article 77-2 of the Pharmaceutical Affairs Law |
Australia | Part 16h of the Therapeutics Goods Regulations, 1990 |
Table 12. Orphan Drug Templates and Submission Tips
Country | Link |
---|---|
EU | EMA |
Japan | National Institute of Biomedical Innovation (NIBIO) |
Table 13. Orphan Drug Product Designation Websites
Country | What Database Provides/Link |
---|---|
US | Orphan drug designations |
EU | Searchable list of EU opinions on rare disease (orphan) designations |
EU | Full list of orphan designations granted by the European Commission |
Japan | List and summary of orphan drug designation |
Australia | Orphan drug designations by drug name |
Table 14. Orphan Drug Databases and Advocacy Group Information
Organization | What They Provide |
---|---|
National Organization for Rare Disorders (NORD) |
Provides a comprehensive summary of a disease (symptoms, causes, population prevalence, related disorders, standard of care [if any], previous orphan drugs already designation and cleared for indication, any investigational therapies, including the patient advocacy groups associated with the disease to help find current literature of other disease information Rare Disease Information Patient Organization Database |
Orpha.net | Provides a comprehensive disease summary and prevalence numbers It also has a drug database where you can input a drug name and it will let you know the global designation status or marketing application approval for an orphan drug. This site is invaluable when mapping out your strategy road map and locating orphan drug information. Global Orphan Drug Designation Database |
EURORDIS (European Rare Disease Organisation) | Provides marketing authorizations for orphan drugs Links to Advocacy Groups RareConnect.org, a EURORDIS initiative, is the growing online network of rare disease communities that brings together thousands of patients, families and groups who might otherwise be isolated. |
NIH Genetic and Rare Disease Information | Provides links to advocacy groups |
National Comprehensive Cancer Network | Provides links to cancer advocacy groups List of approved orphan drugs by indication |
Rare Disease Report | Links to a wide range of advocacy groups |
Table 15. Country Level Clinical Trial Registries
Brazilian Clinical Trials Registry (ReBec)
Chinese Clinical Trial Registry (ChiCTR)
Clinical Research Information Service (CRiS), Republic of Korea
Clinical Trials Registry - India (CTRI)
Cuban Public Registry of Clinical Trials (RPCEC)
EU Clinical Trials Register (EU-CTR)
German Clinical Trials Register (DRKS)
Iranian Registry of Clinical Trials (IRCT)
ISRCTN
Japan Primary Registries Network (JPRN)
Thai Clinical Trials Registry (TCTR)
The Netherlands National Trial Register (NTR)
Pan African Clinical Trial Registry (PACTR)
Sri Lanka Clinical Trials Registry (SLCTR)
Spanish Clinical Studies Registry
US National Institutes of Health
World Health Organization—International Clinical Trials Registry Platform (ICTR)
Table 16. Global Generic Drug Regulations by Country
Generics Law
Guidance to Show Bioequivalence and Bioavailability
(Spanish only)
Registration of Generics
General for Drugs
Table 17. Global Regulatory Authority Websites
Table 18. Global Harmonization Efforts
ASIAN Harmonization Working Party (AHWP)
Asia Pacific Economic Cooperation (APEC)
Association of Southeast Asian Nations
Bilateral Agreements
CARICOM
Global Harmonization Task Force
Gulf Cooperation Council
International Coalition of Medicines Regulatory Authorities
International Conference on Harmonization
ICH-Global Cooperation Group
International Generic Drug Regulators Programme
International Medical Device Regulators Forum (IMDRF)
International Organization for Standardization
International Pharmaceutical Excipients Council
International Pharmaceutical Regulators Forum (IPRF)
Mercado Comun del Sur (MERCOSUR)
Pan American Health Organization
Pan American Network for Drug Regulatory Harmonization (PANDRH)
Pharmaceutical Inspection Cooperation Scheme
World Health Organization
World Health Organization – Region/Country
World Trade Organization
Table 19. Approval Information on Medicinal Products by Country/Region
Table 20. US Compliance Links
Clinical Investigator Inspection List (CIIL) Database
Compliance Manuals
FDA Debarment List
FDA's Electronic Reading Room–Warning Letters
HHS–OIG Fraud Prevention and Detection
Untitled Letters and Notices of Violation
Warning Letters
Table 21. Biotherapeutic Products Regulations, Guidance and Articles by Country
Regulation of Biosimilar Medicines
Guidance Document
Mexican Regulatory Authority Publication on Biosimilars Registration
Article on Promulgation of the law on Biosimilars
Article on Amendment to the law of 2009
Article on Biosimilars Legislation
Medicines Control Council – Biosimilar Medicines Quality, Non-Clinical and Clinical Requirements
Authorisation of Similar Biological Medicinal Products (Biosimilars)
Questions and Answers Concerning the Authorisation of Similar Biological Medicinal Products (Biosimilars)
Regulations (Drug Registration)
Guideline on the Examination and Registration of Drugs—the Guideline on Biosimilar Products